The chapters of our history
1904
The courage of a pioneer
Founded in 1904 by Dr. Valentino Baldacci, Laboratori Baldacci S.p.A. is one of the oldest Italian pharmaceutical companies and the oldest in the Pisa pharmaceutical cluster.
Since the early 1900s, Dr. Valentino Baldacci foresaw the importance of scientific collaboration with the Pisan Academia, aimed at designing and carrying out of accurate pharmaco-toxicological and clinical studies, which enabled the development and commercialization of new original drugs.
Over the years, this scientific collaboration between Industry and the Academic World has been the soul of the Company and has led to the discovery of active ingredients with a high benefit/risk ratio.
1920
Comparisons and Collaborations
The 1920s represent the years of the consolidation of Baldacci Laboratories S.p.A. as a pharmaceutical company in Italy. The developed drugs found the interest of the Medical Class and made the Baldacci’s name synonymous of guarantee of safety and efficacy. Professional expertise and ethical approach were the principles followed in the past, the same ones that allowed the development and success in Italy and abroad and that still represent the soul of the Company today.
1930
Time to pass the borders
Between the two world wars, the Company began its expansion and growth, not only in the Italian market but also abroad.
1949
A valuable library
The library of Laboratori Baldacci S.p.A. represents the “cultural soul” of the company. Following World War II and the 1949 flood, the library was renovated and upgraded. With 15,000 volumes and subscriptions to more than 250 international scientific journals, it became a point of reference for doctors and university students.
1952
Editorial and culture
In the early 1950s, international scientific journals, such as “Omnia Medica et Therapeutica,” “Omnia Medicamenta,” and “Quaderni della Coagulazione,” were edited by Dr. Baldacci, on which pharmacological and clinical papers were published by Italian and foreign researchers, relating mainly, but not only, to the study of coagulation, platelet aggregation, and the coagulation factors.
This initiative of scientific update on the research carried out by the Company and on the advances in international pharmacology, was immediately well appreciated by the Medical Class.
1951
-55
Baldacci around the world
The first half of the 1950s saw Baldacci engaged in the project of expansion abroad.
In 1951 in Brazil and 1955 in Portugal, two companies were created that were destined to grow and become important economic entities in those countries and neighboring markets.
Today
Laboratori Baldacci remains a national Company owned by the Baldacci family, linked to the philosophy and values of its founder. Laboratori Baldacci remains a national Company owned by the Baldacci family, linked to the philosophy and values of its founder.
Today, as in the past, the Company continues to pursue its development model based on a constant commitment to the study of new active ingredients that are the subject of international patents and the production of drugs.
In the last years, the company’s portfolio has been enriched with drugs and medical devices under license from other companies as well as dietary supplements and medical devices conceived and developed in its own Laboratories.
The ever-growing success of Laboratori Baldacci is thanks to its ability to develop products designed to meet the needs and expectations of both physicians and their patients. The presence of a qualified external network of Medical Sales Representatives throughout the country and operating in accordance with the Farmindustria Code of Ethics, represents a company added value.